| Uniprot No. | P0DTC2 |
| Target Names | S |
| Alternative Names | S, S1, S1-RBD, Spike glycoprotein |
| Species Reactivity | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) |
| Immunogen | Recombinant Human Novel Coronavirus Spike glycoprotein (S) (16-685aa) (CSB-MP3324GMY) |
| Immunogen Species | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) |
| Conjugate | Non-conjugated |
| Clonality | Monoclonal |
| Isotype | Mouse scFv fusion with human IgG1 Fc |
| Clone No. | H6 |
| Purification Method | Affinity-chromatography |
| Concentration | It differs from different batches. Please contact us to confirm it. |
| Buffer | Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 |
| Form | Liquid |
| Tested Applications | ELISA, GICA |
| Recommended Dilution | | Application | Recommended Dilution | | ELISA | 1:10000-1:50000 | | GICA | 1:500-1:40000 | |
| Protocols | ELISA Protocol
CSB-RA33245A1GMY ELISA protocol |
| Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
| Description | Recombinant anti-SARS-CoV-2 spike Mouse ScFv is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal. |
